Dr. Tracy T. Ashby
Pulmonology (Pulmonary Disease Physician)
655 W 8th St, Acc, 1st Floor, Primary Care Center
Jacksonville, FL 32209
- Medicare participating
At a glance
- Medical school
- Lincoln Memorial University Medical Department (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 246
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Lincoln Memorial University Medical Department
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
FL license OS13314
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Shands Jacksonville Jacksonville, FL
Medical groups
- University of Florida Jacksonville Physicians, Inc. (910 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 246
- Services billed
- 579
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 227 | 79 |
| Established patient office or other outpatient visit, 30-39 minutes | 83 | 64 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 58 | 27 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 34 | 20 |
| New patient office or other outpatient visit, 45-59 minutes | 22 | 22 |
| Established patient office or other outpatient visit, 40-54 minutes | 19 | 17 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 17 | 16 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | 11 |
| Test for exercise-induced lung stress | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Jacksonville, FL | 174 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Jacksonville, FL | 123 |
| Montelukast Sodium Other prescribers in Jacksonville, FL | 52 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Jacksonville, FL | 41 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Jacksonville, FL | 40 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Jacksonville, FL | 37 |
| Incruse Ellipta (umeclidinium bromide) Other prescribers in Jacksonville, FL | 35 |
| Prednisone Other prescribers in Jacksonville, FL | 32 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Jacksonville, FL | 23 |
| Fluticasone Propionate Other prescribers in Jacksonville, FL | 23 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 10 payments worth $965 in total to this clinician.
| Intuitive Surgical, Inc. | $391 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $142 |
| Pulmonx Corporation | $129 |
| Insmed, Inc. | $116 |
| Grifols Shared Services North America, Inc. | $97.02 |
| GlaxoSmithKline, LLC. | $44.89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.13 |
| Amgen Inc. | $14.91 |
| Food and Beverage | $965 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $63,775 in research payments for these studies, mostly to the institutions running them.
- A Phase III, Multicentre, Randomised, Double blind, Parallel group, Placebo controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Su…
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.